Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Treasury Shares (2018 - 2025)

Health Catalyst's Treasury Shares history spans 8 years, with the latest figure at $2.5 million for Q4 2025.

  • For Q4 2025, Treasury Shares rose 380.96% year-over-year to $2.5 million; the TTM value through Dec 2025 reached $2.5 million, up 380.96%, while the annual FY2025 figure was $2.5 million, 380.96% up from the prior year.
  • Treasury Shares reached $2.5 million in Q4 2025 per HCAT's latest filing, down from $2.6 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $5.7 million in Q1 2025 to a low of $145027.0 in Q1 2023.
  • Average Treasury Shares over 5 years is $1.3 million, with a median of $524313.0 recorded in 2024.
  • Peak YoY movement for Treasury Shares: surged 1160.74% in 2022, then tumbled 96.39% in 2023.
  • A 5-year view of Treasury Shares shows it stood at $319442.0 in 2021, then skyrocketed by 121.99% to $709139.0 in 2022, then crashed by 79.55% to $145027.0 in 2023, then skyrocketed by 261.53% to $524313.0 in 2024, then soared by 380.96% to $2.5 million in 2025.
  • Per Business Quant, the three most recent readings for HCAT's Treasury Shares are $2.5 million (Q4 2025), $2.6 million (Q3 2025), and $2.7 million (Q2 2025).